Update on third-generation EGFR tyrosine kinase inhibitors

被引：7
作者：
Gray, Jhanelle
Haura, Eric
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Dept Thorac Oncol & Chem Biol, Tampa, FL 33612 USA
[2] H Lee Moffitt Canc Ctr & Res Inst, Program Mol Med, Tampa, FL 33612 USA
来源：
TRANSLATIONAL LUNG CANCER RESEARCH | 2014年 / 3卷 / 06期
关键词：
D O I：
10.3978/j.issn.2218-6751.2014.09.08
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：360 / 362
页数：3
相关论文
共 12 条
  • [1] Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non-Small-Cell Lung Cancer
    Jackman, David
    Pao, William
    Riely, Gregory J.
    Engelman, Jeffrey A.
    Kris, Mark G.
    Jaenne, Pasi A.
    Lynch, Thomas
    Johnson, Bruce E.
    Miller, Vincent A.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (02) : 357 - 360
  • [2] Phase I/II Trial of Cetuximab and Erlotinib in Patients with Lung Adenocarcinoma and Acquired Resistance to Erlotinib
    Janjigian, Yelena Y.
    Azzoli, Christopher G.
    Krug, Lee M.
    Pereira, Leanne K.
    Rizvi, Naiyer A.
    Pietanza, M. Catherine
    Kris, Mark G.
    Ginsberg, Michelle S.
    Pao, William
    Miller, Vincent A.
    Riely, Gregory J.
    [J]. CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2521 - 2527
  • [3] Janjigian YY, 2012, ANN ONCOL, V23, P12270, DOI DOI 10.1093/ANN0NC/MDS466
  • [4] Janjigian YY, 2011, J CLIN ONCOL S, V29
  • [5] Janne PA, 2014, J CLIN ONCOL S, V32
  • [6] LUX-Lung 4: A Phase II Trial of Afatinib in Patients With Advanced Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment With Erlotinib, Gefitinib, or Both
    Katakami, Nobuyuki
    Atagi, Shinji
    Goto, Koichi
    Hida, Toyoaki
    Horai, Takeshi
    Inoue, Akira
    Ichinose, Yukito
    Koboyashi, Kunihiko
    Takeda, Koji
    Kiura, Katsuyuki
    Nishio, Kazuto
    Seki, Yoko
    Ebisawa, Ryuichi
    Shahidi, Mehdi
    Yamamoto, Nobuyuki
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) : 3335 - +
  • [7] Kim D-W, 2014, ASCO M, V32, P8011
  • [8] Gefitinib or Carboplatin-Paclitaxel in Pulmonary Adenocarcinoma.
    Mok, Tony S.
    Wu, Yi-Long
    Thongprasert, Sumitra
    Yang, Chih-Hsin
    Chu, Da-Tong
    Saijo, Nagahiro
    Sunpaweravong, Patrapim
    Han, Baohui
    Margono, Benjamin
    Ichinose, Yukito
    Nishiwaki, Yutaka
    Ohe, Yuichiro
    Yang, Jin-Ji
    Chewaskulyong, Busyamas
    Jiang, Haiyi
    Duffield, Emma L.
    Watkins, Claire L.
    Armour, Alison A.
    Fukuoka, Masahiro
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (10) : 947 - 957
  • [9] Schuler MH, 2014, J CLIN ONCOL, V35
  • [10] Phase III Study of Afatinib or Cisplatin Plus Pemetrexed in Patients With Metastatic Lung Adenocarcinoma With EGFR Mutations
    Sequist, Lecia V.
    Yang, James Chih-Hsin
    Yamamoto, Nobuyuki
    O'Byrne, Kenneth
    Hirsh, Vera
    Mok, Tony
    Geater, Sarayut Lucien
    Orlov, Sergey
    Tsai, Chun-Ming
    Boyer, Michael
    Su, Wu-Chou
    Bennouna, Jaafar
    Kato, Terufumi
    Gorbunova, Vera
    Lee, Ki Hyeong
    Shah, Riyaz
    Massey, Dan
    Zazulina, Victoria
    Shahidi, Mehdi
    Schuler, Martin
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (27) : 3327 - +
12